Search research articles
Contact Us
Filters
Showing results (101-110 of 377) with videos related to
Page
of 38
Sort By:
Critical Reviews in Oncology/Hematology
|
July 13, 2024
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success
Lorenzo Belluomini, Alice Avancini, Marco Sposito, et al.
Cancer Treatment Reviews
|
June 13, 2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients
Emilio Bria, Mariangela Ciccarese, Diana Giannarelli, et al.
Minerva Surgery
|
August 2, 2021
Validation of a prognostic model including the number of harvested lymph-nodes in the setting of non-small cell lung cancer patients undergoing curative resection: a multicenter analysis
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Expert Opinion on Biological Therapy
|
November 8, 2008
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
Emilio Bria, Federica Cuppone, Michele Milella, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
September 12, 2018
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Expert Review of Anticancer Therapy
|
June 13, 2020
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives
Giulia Sartori, Lorenzo Belluomini, Fiorella Lombardo, et al.
Future Oncology (London, England)
|
March 6, 2024
Response to first-line pembrolizumab in metastatic <i>KRAS</i>-mutated non-small-cell lung cancer
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, et al.
Current Pharmaceutical Design
|
October 22, 2013
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'
Sara Pilotto, Maria Bonomi, Francesco Massari, et al.
Clinical Lung Cancer
|
May 12, 2020
Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Cancer
|
June 29, 2004
Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma
Michele Milella, Alain Gelibter, Serena Di Cosimo, et al.
Page
of 38
Search research articles
Search
Showing results (101-110 of 377) with videos related to
Sort By:
Page
of 38
Critical Reviews in Oncology/Hematology
|
July 13, 2024
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success
Lorenzo Belluomini, Alice Avancini, Marco Sposito, et al.
Cancer Treatment Reviews
|
June 13, 2006
Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients
Emilio Bria, Mariangela Ciccarese, Diana Giannarelli, et al.
Minerva Surgery
|
August 2, 2021
Validation of a prognostic model including the number of harvested lymph-nodes in the setting of non-small cell lung cancer patients undergoing curative resection: a multicenter analysis
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Expert Opinion on Biological Therapy
|
November 8, 2008
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
Emilio Bria, Federica Cuppone, Michele Milella, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
September 12, 2018
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Expert Review of Anticancer Therapy
|
June 13, 2020
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives
Giulia Sartori, Lorenzo Belluomini, Fiorella Lombardo, et al.
Future Oncology (London, England)
|
March 6, 2024
Response to first-line pembrolizumab in metastatic <i>KRAS</i>-mutated non-small-cell lung cancer
Sabrina Rossi, Arianna Pagliaro, Giovanna Finocchiaro, et al.
Current Pharmaceutical Design
|
October 22, 2013
Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: a 'hard days night'
Sara Pilotto, Maria Bonomi, Francesco Massari, et al.
Clinical Lung Cancer
|
May 12, 2020
Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis
Marco Chiappetta, Giovanni Leuzzi, Isabella Sperduti, et al.
Cancer
|
June 29, 2004
Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma
Michele Milella, Alain Gelibter, Serena Di Cosimo, et al.
Page
of 38